chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash flare ups; hypersensitivity reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (hypersensitivity reaction) and RASH (rash flare ups) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     The patient's past medical history included Heart disorder in 2012, Brain tumor in 1996, Osteoarthritis since 2019 and Thyroid disorder in 1997. Concurrent medical conditions included Sulfonamide allergy, Drug allergy (Quinolones allergy), Drug allergy and Drug allergy (Zonisamide allergy) in May 2021. Concomitant products included BENAZEPRIL for Blood pressure, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for GERD, THYROID (ARMOUR THYROID) for Thyroid disorder, RANOLAZINE for an unknown indication, TOPIRAMATE (TOPAMAX) for seisures.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced HYPERSENSITIVITY (hypersensitivity reaction). On 15-Apr-2021, the patient experienced RASH (rash flare ups). At the time of the report, HYPERSENSITIVITY (hypersensitivity reaction) and RASH (rash flare ups) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was taking Seizure medication concomitantly. The patient was prescribed with steroid pack, to relieve the symptoms. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-046335, MOD-2021-046304 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: patient medical history updatedConcomitant codded
Red rash developed about one week after injection and is very itchy.  It also hurts a little under my arm when I move it.
She also mentioned that she also got Moderna; She also mentioned that she also got Moderna; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  A 73-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose Number Unknown. Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown" and all described as "She also mentioned that she also got Moderna".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 11/27/2001 the patient developed several papules, firm vesicles, scattered over his body, on his face, back and groin area. The patient was exposed to chicken pox 2 weeks ago.
flare of gout, elevated HSCRP>10, ESR 22, d-dimer 0.64
fingers and hands were a little bit swollen; swollen in calves; feels as if her whole body is holding water; left temple is starting to feel like she's getting headache; feet were a tad swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (feet were a tad swollen), PERIPHERAL SWELLING (fingers and hands were a little bit swollen), PERIPHERAL SWELLING (swollen in calves), SWELLING (feels as if her whole body is holding water) and HEADACHE (left temple is starting to feel like she's getting headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concomitant products included AZITHROMYCIN (Z-PAK) for Bronchitis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), ASCORBIC ACID (VIT C), VIT D [VITAMIN D NOS], TOCOPHEROL (VIT E [TOCOPHEROL]), ZINC, IRON, PROGESTERONE, TESTOSTERONE, ESTRADIOL (ESTROGEN), VITAMIN B6, UBIDECARENONE, VITAMIN E NOS (COQ10 COMPLEX), VITAMIN B12 NOS, VITAMIN B [VITAMIN B NOS], MULTIVITAMINS [VITAMINS NOS] and THYROID (NATURE THROID) for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PERIPHERAL SWELLING (feet were a tad swollen). On 28-Mar-2021, the patient experienced PERIPHERAL SWELLING (fingers and hands were a little bit swollen), PERIPHERAL SWELLING (swollen in calves), SWELLING (feels as if her whole body is holding water) and HEADACHE (left temple is starting to feel like she's getting headache). At the time of the report, PERIPHERAL SWELLING (feet were a tad swollen), PERIPHERAL SWELLING (fingers and hands were a little bit swollen), PERIPHERAL SWELLING (swollen in calves), SWELLING (feels as if her whole body is holding water) and HEADACHE (left temple is starting to feel like she's getting headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications also included gamma vitamins. The patient had Z-pak for bronchitis 2 weeks ago. No treatment information was provided.
dizziness; fatigue; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), FATIGUE (fatigue) and HEADACHE (slight headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0F7A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced DIZZINESS (dizziness), FATIGUE (fatigue) and HEADACHE (slight headache). At the time of the report, DIZZINESS (dizziness), FATIGUE (fatigue) and HEADACHE (slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications were not provided.
Administered pneumovax IM to right deltoid. Following day, right deltoid had hard, reddened area about 3-4 inch circumference. Employee feeling malaise, no fever, warm and tender site.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/28/2022 ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD) ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/7/2023 ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD) HYPOXIA 11/28/2022 ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD)
Her mother is legally blind with vision that is like "looking through a straw" due to glaucoma progression/After the second dose caller reports that her mother can no longer see anything; Needs help for everything, has not been able to get around the house or feed herself; This spontaneous case was reported by a consumer and describes the occurrence of BLINDNESS (Her mother is legally blind with vision that is like "looking through a straw" due to glaucoma progression/After the second dose caller reports that her mother can no longer see anything) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B12A and 025B12A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Glaucoma (She was blind with vision due to glaucoma progression. Patient had not seen any eye doctor or taken any eye medication  in the last five years.) since an unknown date and Glaucoma.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced BLINDNESS (Her mother is legally blind with vision that is like "looking through a straw" due to glaucoma progression/After the second dose caller reports that her mother can no longer see anything) (seriousness criterion medically significant) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Needs help for everything, has not been able to get around the house or feed herself). At the time of the report, BLINDNESS (Her mother is legally blind with vision that is like "looking through a straw" due to glaucoma progression/After the second dose caller reports that her mother can no longer see anything) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Needs help for everything, has not been able to get around the house or feed herself) had not resolved.            No concomitant medications was reported Treatment information was not provided  Action taken with mRNA-1273 in response to the event was not applicable  Very limited information regarding this event has been provided at this time.  Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Upon internal review on 16-Sep-2022, non-significant correction was performed to update case received from field.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
3 days post immunization, child presented to the office with 7 x 9 cm area of erythema and increased warmth to mid right thigh.  She had received her 5th DTaP/1st HEP A intramuscular injections and her second subcutaneous MMR in that leg.  The child did not complain of any pain or fever.
15Apr08 had Pelvic exam and received HPV vaccine about 1430. 15Apr08 at 1800 went to ER for 'lipothymic episode' and diarrhea. No fever. Syncopal episode. IV F 1l given. 15Apr08 at about 1700 sweating, felt hot, diarrhea but also had 1 episode with vacc, pale, dizzy, shaky.
This spontaneous report was received from a registered nurse regarding multiple unspecified patients of unknown age. There was no information about concurrent conditions and historical medication. On an unknown date the patients were vaccinated with (Oka-Merck) PROQUAD, lot # L023114, expiration date -24-DEC-2016, lot # L033698, expiration date- 28-FEB-2017, lot # L021601, expiration date- 10-DEC-2016 and lot # L034931, expiration date- 03-MAR-2017. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. Temperature was -3 degree Celsius, Time frame was 6 hours and it was back in range. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was hospitalized within  6 weeks of receiving COVID vaccination. Diagnosis was triple vessel coronary artery disease.
After was given Varivax and flu vaccine c/o throat being scratch and respiratory distress. Given Benadryl, epi pen jr, O2 by face mask and transported to hospital
flare up of Complex regional pain syndrome; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (flare up of Complex regional pain syndrome) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concurrent medical conditions included Complex regional pain syndrome (flare up of Complex regional pain syndrome (CRPS) of right arm and spread to left arm.). Concomitant products included FLUTICASONE PROPIONATE (FLOVENT), LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX), TRAMADOL, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and AZELASTINE for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced CONDITION AGGRAVATED (flare up of Complex regional pain syndrome). At the time of the report, CONDITION AGGRAVATED (flare up of Complex regional pain syndrome) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
10-14-09 Clt called to report severe pain 3 days after flu shot was given in left arm. Unable to raise left arm-pain radiates, down left arm and shoulder. Apt. made for Oct 28, 09-Dr. (orthopedic). States slowly getting better.
"Body aches", "joint ache" Myalgias, arthralgias, weakness to legs. No treatment.
1). Arm soreness much worse than usual within a couple of hour 2). Severe body aches after 6 hours or so. 3). Woke up at night with worst rigors I have ever had. I was almost unable to walk to the bathroom to get water 4). Next morning, rigors gone, but persistent body aches with a severe headache
8/10 Headache, pain 7/10 and stiffness in back and neck, swollen lymph nodes on neck, periods of dizziness and nausea.  Extremely sore arm 10/10, unable to lift.
pt seen 3MAY96 @ 1145AM local rxn baseball size warm, red & swollen;mom noticed 1 diameter redness & swelling 4PM;phone MD office @ 440PM stating this to give DPH & use cool cloth;
Information has been received from the VAERS database via a journalist. This spontaneous report as received from a other refers to a patient of unknown age. The patient was vaccinated with lot # (652965/0622F) ZOSTAVAX on 29-NOV-2006. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced herpes zoster. No treatment information was reported. The outcome of herpes zoster is unknown. The relatedness for herpes zoster is unknown for ZOSTAVAX. Additional information is not expected.
Severe pain in shoulder, so severe I was unable to raise my arm.  Severe pain abated some after 3 days, but the pain continues and it is a full month later - 11/21/2013.
After receiving the Janssen vaccine at 3:30pm, patient started filling dizzy and lightheaded. He was clammy to the touch and was sweating profusely. Vitals were checked and blood pressure/pulse were normal. Ice was applied to patient's wrist and neck. Patient was till complaining he was not feeling well and was sweating.  Pharmacist had patient lie down on the floor. Paramedics were called to the scene. They also checked his vitals and they were good. Patient refused to go to hospital and stated that he was feeling better.   Everything happened right after the patient received the vaccine. It was not a delayed reaction.
Patient reports that  woke up today (10/29) with and area (15cm x 9cm) of mild  swelling,  redness, and warmth just below the injection site. The area is tender to touch.
She had soreness at the COVID-19 Vaccine injection site with the first COVID-19 Vaccine shot; This is a spontaneous report from a contactable consumer. This 58-year-old female consumer (patient) reported for herself that.  A 58-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0167; Expiration Date: 31Aug2021), via an unspecified route of administration, administered in arm right on 26May2021 as (At the age of 58-years) dose 1, single for COVID-19 immunisation. Medical history included type 1 diabetes mellitus from 1996 and ongoing. The patient concomitant medications were not reported. The patient experienced she had soreness at the COVID-19 vaccine injection site with the first COVID-19 vaccine shot on 26May2021. It was reported that she was calling about the COVID-19 vaccine and wanted to know about a side effect she may have experienced. She said she had soreness at the COVID-19 vaccine injection site with the first and second COVID-19 vaccine shots. She clarified both COVID-19 vaccine shots were given in her right arm. She said the soreness (in her right arm) went away after 1-2 days with both COVID-19 Vaccine shots. She said she noticed after her second COVID-19 Vaccine shot that she had muscle pain in her opposite arm (clarified as her left arm). She said she noticed the left arm muscle pain more as 01Jul2021 came closer. She said the healthcare professional, who gave her the second COVID-19 Vaccine shot, told her 01Jul2021 would be the day the COVID-19 vaccine would be complete (2 weeks after her second COVID-19 Vaccine shot). It was reported the last week, or so (clarified as the end of Jun2021), her left arm muscle felt very uncomfortable when she lifted her arm. She said she regularly did stress training with weights. She said she guessed she always felt the left arm muscle pain (after she had her second COVID-19 Vaccine shot). She said her left arm muscle was a little sore, but she noticed the left arm muscle soreness even more while training during the last week of Jun2021 (starting around 28Jun2021). She said she was wondering why she would have pain in her left arm muscle, since she was given both COVID-19 vaccine doses in her right arm. Caller asked if anybody else had reported that kind of side effect. The caller was advised she would be transferred to Pfizer Medical Information for further assistance. Right arm injection site pain Treatment: Declined any and left arm muscle pain Treatment: Reported she applied Biofreeze (gel) on her left shoulder Monday (05Jul2021) and Tuesday (06Jul2021) and her left arm muscle was not as painful as it was prior to that. It was reported that her endocrinologist ordered blood work on 08Jun2021 to test her parathyroid level and calcium levels. No further details provided. Reporter seriousness for She had soreness at the COVID-19 Vaccine injection site with the first COVID-19 Vaccine shot: Unspecified. The outcome of event was resolved on May2021.  Follow-Up (27Jul2021): Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a 8 year old patient who in August 2008, was vaccinated with a dose of ZOSTAVAX (lot no. 659763/1875U) SC, instead of the second dose of VARIVAX. The physician noted that although the VARIVAX and ZOSTAVAX vials look alike, the names of the vaccines were clearly written in large letters. This is one of several reports from the same source. Additional information has been requested.
Vaccine was given, but vaccinator did not see expiration date until after it was given. Vaccine was administered expired.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with the first dose of Gardasil. Subsequently, following vaccination, the patient lost consciousness. The patient regained consciousness after a few minutes. Unspecified medical attention was sought. Additional information has been requested.
Had the shots , but have shingles/ suspected vaccination failure; shingles on ear; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and herpes zoster otitis externa (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and herpes zoster otitis externa were unknown.   It was unknown if the reporter considered the vaccination failure and herpes zoster otitis externa to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shots but had shingles on ear. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Fever, chills starting 48 hours after injection Fever, chills reaccurred again after the next 24 hours.
Pt began having sx's 6 day post vaccination. Occipital, Dull ache, constant headache
Approximately 12 hours after receiving second Pfizer shot patient started feeling feverish, within 6 hours was profusely sweating with chills, wrapped in blankets in 85 degree environment.  Started throwing up overnight, severe full body aching and headache.  Continued severe vomiting, diarrhea, and chills for approximately 48 hours.
Day-horizontal watching TV. Nothing strenuous for says before and during. Evening, swollen RIGHT middle finger KNUCKLE and painful. Continued to increase in pain. Saw Dr a few months later. Xray normal. Month later mri normal. Week later, pain moved up arm into elbow. Pain is constant increasing in intensity. Knuckle still swollen. Can't brush hair or scratch back or scoop cat litter without severe arm pain. Knuckle still swollen and hurts. Will follow up with doctor soon. Started day OF shot. No other reasons or activities to cause it. No tick bites no changes in environment or illnesses or scratches or strenuous activity. Very frustrated. I know that shot caused this and I am NOT an antivaxer. But this caused my pain and there is no resolution or end to it. My daughter still got both her shots. But I know something j. The shot triggered this in me.  Because of this, I did not get my second shot.
Patient presented on 10/10 with persistent emesis/inability to tolerate PO intake. Discharged home after reassuring UGI and PO trial in ED. Represented on 10/13 in extremis. Found to have an acute surgical abdomen with ileocolic intussusception and narrowing at the terminal ileum noted on exploratory laparotomy.
Got a diagnosis of COVID-19 between the two doses/In the mean time he has been diagnosed with COVID. He was diagnosed on either Monday or Tuesday of this week; This is a spontaneous report from a non-contactable consumer. This consumer reported for a 95-year-old male patient (father) who received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Not Provided), via an unspecified route of administration on 29Jan2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer-BioNTech COVID-19 vaccine on 29Jan2021 and scheduled for second on 19Feb2021. In the mean time between the two doses he had been diagnosed with COVID. He was diagnosed on either Monday or Tuesday of this week (08Feb2021 or 09Feb2021). The reporter asked would the diagnosis of COVID affect the second dose of the vaccine and what to do from now. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown result on an unspecified date. The outcome of event was unknown.   No follow-up attempts are possible: information about lot/batch number cannot be obtained.